FOREST BASKETT Insider Trading $ATHR ATHEROS COMMUNICATIONS INC

Get the latest insider transactions of FOREST BASKETT. FOREST BASKETT is 10% Owner in ARCA biopharma, Inc. ($ABIO) and 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and 10% Owner in Marker Therapeutics, Inc. ($MRKR) and 10% Owner in SUNESIS PHARMACEUTICALS INC ($SNSS) and Director in ATHEROS COMMUNICATIONS INC ($ATHR) and 10% Owner in Achaogen Inc ($AKAO) and Director in Tableau Software Inc ($DATA) and 10% Owner in Liquidia Technologies Inc ($LQDA) and 10% Owner in AVEO PHARMACEUTICALS INC ($AVEO) and 10% Owner in INNERWORKINGS INC ($INWK) and 10% Owner in SUPERNUS PHARMACEUTICALS INC ($SUPN) and 10% Owner in MULESOFT, INC ($MULE) and 10% Owner in HYPERION THERAPEUTICS INC ($HPTX) and 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and 10% Owner in Cascadian Therapeutics, Inc. ($CASC) and 10% Owner in Care.com Inc ($CRCM) and 10% Owner in PEPLIN INC ($PLIN) and 10% Owner in ARDELYX, INC. ($ARDX) and 10% Owner in APPIAN CORP ($APPN) and 10% Owner in Mersana Therapeutics, Inc. ($MRSN) and 10% Owner in GENOCEA BIOSCIENCES, INC. ($GNCA) and 10% Owner in Roka BioScience, Inc. ($ROKA) and 10% Owner in Cloudflare, Inc. ($NET) and 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and 10% Owner in TESARO, Inc. ($TSRO) and 10% Owner in Regulus Therapeutics Inc. ($RGLS) and 10% Owner in Sprout Social, Inc. ($SPT) and 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and 10% Owner in Cerecor Inc. ($CERC) and 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and 10% Owner in Epizyme, Inc. ($EPZM) and 10% Owner in Adaptimmune Therapeutics PLC ($ADAP) and 10% Owner in Metacrine, Inc. ($MTCR) and 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and 10% Owner in Inozyme Pharma, Inc. ($INZY) and 10% Owner in Elastic N.V. ($ESTC) and 10% Owner in Eargo, Inc. ($EAR) and 10% Owner in Akouos, Inc. ($AKUS) and 10% Owner in Surface Oncology, Inc. ($SURF) and 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM) and 10% Owner in Nkarta, Inc. ($NKTX).